Formulations:
- Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial
- Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial
Indications:
- Multiple sclerosis
- Follicular lymphoma
- Diffuse large B-cell lymphoma, not otherwise specified
- Chronic lymphocytic leukaemia or small lymphocytic lymphoma
- Burkitt lymphoma including Burkitt leukaemia
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial
- Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial
Indications:
- Multiple sclerosis
- Follicular lymphoma
- Diffuse large B-cell lymphoma, not otherwise specified
- Chronic lymphocytic leukaemia or small lymphocytic lymphoma
- Burkitt lymphoma including Burkitt leukaemia
Source: EML workbook import